Your browser doesn't support javascript.
loading
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Krausz, Máté; Mitsuiki, Noriko; Falcone, Valeria; Komp, Johanna; Posadas-Cantera, Sara; Lorenz, Hanns-Martin; Litzman, Jiri; Wolff, Daniel; Kanariou, Maria; Heinkele, Anita; Speckmann, Carsten; Häcker, Georg; Hengel, Hartmut; Gámez-Díaz, Laura; Grimbacher, Bodo.
Afiliación
  • Krausz M; Institute for Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Mitsuiki N; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Falcone V; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Komp J; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Posadas-Cantera S; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lorenz HM; Institute of Virology, University Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Litzman J; Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Wolff D; Institute for Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kanariou M; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Heinkele A; Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Speckmann C; Division of Rheumatology, Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Häcker G; Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno and Medical Faculty, Masaryk University, Brno, Czechia.
  • Hengel H; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Gámez-Díaz L; Department of Immunology and Histocompatibility, Centre for Primary Immunodeficiencies, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Grimbacher B; Center for Pediatric Rheumatology, Olgahospital, Stuttgart, Germany.
Front Immunol ; 13: 1011646, 2022.
Article en En | MEDLINE | ID: mdl-36405723

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Herpesvirus Humano 4 / Infecciones por Virus de Epstein-Barr Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Herpesvirus Humano 4 / Infecciones por Virus de Epstein-Barr Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article